AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis

Weidong Ji1, Yonghao Li2, Yun He3

  • 1The First Affiliated Hospital, Center for Translational Medicine, Sun Yat-sen University, Guangzhou, China.

Cancer Research
|July 4, 2015
PubMed

Insights

The tumor suppressor AIP1 inhibits tumor growth and metastasis by blocking VEGFR2 signaling in the tumor microenvironment. Loss of AIP1 in vascular cells promotes tumor angiogenesis and EMT, increasing cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor-suppressor AIP1 is known to inhibit epithelial-mesenchymal transition (EMT) in tumor cells.
  • The role of AIP1 within the tumor microenvironment, particularly in vascular endothelial cells (ECs), remains unexplored.

Purpose of the Study:

  • To investigate the function of AIP1 in the tumor microenvironment.
  • To elucidate the mechanisms by which AIP1 influences tumor growth, angiogenesis, and metastasis.

Main Methods:

  • Utilized mouse models with global or EC-specific AIP1 gene deletion.
  • Analyzed tumor growth, neovascularization, and premetastatic niche formation in melanoma and breast cancer models.
  • Investigated VEGFR2 signaling pathways and AIP1's direct interaction with VEGFR2.

Main Results:

  • AIP1 deficiency in the vascular environment significantly augmented tumor growth and metastasis.
  • AIP1-deficient ECs enhanced tumor neovascularization and premetastatic niche formation.
  • AIP1 loss increased VEGFR2 signaling, which was reversed by VEGFR2 kinase inhibitors; AIP1 directly binds to VEGFR2's activation loop.

Conclusions:

  • AIP1 suppresses tumor growth and metastasis by inhibiting VEGFR2-dependent signaling in the tumor niche.
  • AIP1's function in the tumor microenvironment is critical for preventing EMT, angiogenesis, and premetastatic niche formation.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression02:07

Tumor Progression

3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K